๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

The global burden of trachomatous visual impairment: II. assessing burden

โœ Scribed by Timothy G. Evans; M. Kent Ranson


Publisher
Springer Netherlands
Year
1995
Tongue
English
Weight
955 KB
Volume
19
Category
Article
ISSN
0165-5701

No coin nor oath required. For personal study only.

โœฆ Synopsis


This paper builds on results of a previous paper on the prevalence of trachomatous visual impairment as the foundation for assessing the global burden of trachomatous blindness and low vision: approximately 2.9 million cases of trachomatous blindness and 3.8 million low visioned corresponding to a global prevalence of trachomatous visual impairment equal to 1.3/1,000 in 1990 was estimated. For each visually impaired person, the years of life lost due to premature mortality and the years lived in a handicapped state are added to yield a single measure of disease burden called handicap adjusted life years (HALYs). Age, gender and visual acuity group specific HALYs are multiplied by the prevalence of trachomatous visual impairment to yield an estimate of the global burden of trachoma visual impairment equal to 80 million HALYs. Analysis of the distribution of the global burden by age, gender, visual acuity and region provide direction for trachoma research and programme priorities. Sensitivity analysis reveals that the burden estimates of trachomatous visual impairment may vary from as low as 15 million to as high as 500 million HALYs. Given this degree of variability, burden comparisons with other blinding and non-blinding conditions for the purposes of identifying health sector priorities may be misleading.


๐Ÿ“œ SIMILAR VOLUMES


The global burden of trachomatous visual
โœ M. Kent Ranson; Timothy G. Evans ๐Ÿ“‚ Article ๐Ÿ“… 1995 ๐Ÿ› Springer Netherlands ๐ŸŒ English โš– 844 KB

This paper summarizes primary epidemiologic studies of trachomatous blindness to develop age-/sex-/region-specific estimates of the global prevalence of trachomatous blindness and low vision. These studies are first examined for their validity and then employed to derive a 'minimum' prevalence of tr